Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 3/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | SNCA | P37840 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28978538 | 0.79 | — | — | |
| SCHEMBL27912769 | 0.76 | LMNA (0.52) | CYP2D6TSHRLMNA | |
| SCHEMBL28010163 | 0.76 | LMNA (0.52) | CYP2D6TSHRLMNA | |
| SCHEMBL38654833 | 0.74 | CYP1A2 (0.31) | CYP1A2CYP2D6TSHRCYP3A4 | |
| SCHEMBL23414347 | 0.72 | MAOB (0.33) | MAOBCYP1A2CYP2D6TSHRCYP3A4 | |
| SCHEMBL28938422 | 0.71 | MIF (0.43) | CYP3A4 | |
| SCHEMBL17676851 | 0.71 | NPC1 (0.38) | MAOBTSHRCYP3A4LMNAMAOA | |
| SCHEMBL38659464 | 0.69 | L3MBTL1 (0.37) | — | |
| SCHEMBL3590339 | 0.69 | TSHR (0.50) | MAOBCYP1A2CYP2D6TSHRCYP3A4 | |
| SCHEMBL28462034 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916748-A | Indole derivatives as alpha-1 antitrypsin modulators for the treatment of alpha-1 antitrypsin deficiency (AATD) | 弗特克斯药品有限公司 | 2023-04-04 | — | — | CN | disclosed |